Payer coverage trends of anti-obesity medications on commercial formularies
-
Michelle Friedman
-
Shaila Yoshida
Key highlights:
- Current commercial insurance coverage and utilization management tools for AOMs
- Employer rider policies and anticipated shift to traditional formularies
- Challenges in managing AOM costs, long-term efficacy data, and member adherence
- Opportunities to improve access and outcomes with real-world evidence
Discover how payer decision-making is shaping the commercial AOM landscape and gain insights into the evolving dynamics of coverage and management.
Download the report now
Connect with our team
Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.
Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.